ArticleCureus2025
Delivery in a Pregnant Woman With Pulmonary Arterial Hypertension (PAH): A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases in pregnant women are a challenge in pregnancy and perinatal care, representing a significant cause of perinatal death among this population. In this case report, we describe a 41-year-old pregnant woman with atrial septal defect (ASD) type II, 30 mm in size, and secondary pulmonary arterial hypertension (PAH), who was admitted to the Department of Obstetrics and Perinatology for delivery at 35+5 weeks of her first pregnancy. During the first trimester, the patient's attending cardiologist decided to use a wearable cardioverter defibrillator on the patient until the end of the pregnancy and postpartum. At 36+0 weeks of pregnancy, the pregnancy was finished by elective cesarean section by an experienced obstetric and anesthetic team in a cardiosurgery operating room with extracorporeal membrane oxygenation (ECMO) access. The patient remained hemodynamically stable in time, and after the procedure, the newborn received 10 pt. Apgar. After the procedure and during the hospitalization until hospital discharge, the patient did not require emergency interventions. In conclusion, women with PAH should be advised against becoming pregnant, but if a woman becomes pregnant and does not consent to terminate the pregnancy, advanced multidisciplinary care should be provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.